Improved physical functioning and work productivity in ankylosing spondylitis (AS) patients who were treated with adalimumab-ATLAS trial results

Improved physical functioning and work productivity in ankylosing spondylitis (AS) patients who were treated with adalimumab-ATLAS trial results

Bibliographic Details
Main Authors:	Vanderheijde, D, Wordsworth, P, Luo, M, Mease, P, Reveille, J, Zeidler, H, Breban, M, Westhovens, R, Chmiel, J, Chen, N, Wong, R, Davis, J
Format:	Conference item
Published:	2007

Similar Items

Adalimumab improves physical functioning and work productivity in ankylosing spondylitis (AS) patients: Results from ATLAS.
by: van der Heijde, D, et al.
Published: (2006)

Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).
by: Revicki, D, et al.
Published: (2008)

Adalimumab improves health-related quality of life in patients with active ankylosing spondylitis - The ATLAS trial.
by: Van der Heijde, D, et al.
Published: (2005)

Adalimumab enhances health-related quality of life in patients with active ankylosing spondylitis - Results from the atlas trial
by: van der Heijde, D, et al.
Published: (2006)

Improvements in health related quality of life (HRQL) correlate positively with clinical reponses in ankylosing spondylitis (AS) patients - Results from ATLAS
by: Van der Heijde, D, et al.
Published: (2006)

Genetics of ankylosing spondylitis.
by: Brown, M, et al.
Published: (2002)

Treatment with adalimumab reduces signs and symptoms and induces partial remission in patients with ankylosing spondylitis (AS): 1-year results from ATLAS.
by: van der Heijde, D, et al.
Published: (2006)

Efficacy and safety of adalimumab in ankylosing spondylitis
by: Mounach A, et al.
Published: (2014-08-01)

Efficacy of adalimumab in uveitis in patients with ankylosing spondylitis
by: Shandor Fedorovich Erdes
Published: (2012-03-01)

Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
by: Tatyana Valentinovna Mezenova, et al.
Published: (2012-04-01)

Axial spondyloarthritis: A new disease entity, not necessarily early ankylosing spondylitis
by: Robinson, P, et al.
Published: (2012)

Axial spondyloarthritis: A new disease entity, not necessarily early ankylosing spondylitis
by: Robinson, P, et al.
Published: (2013)

Axial spondyloarthritis: a new disease entity, not necessarily early ankylosing spondylitis.
by: Robinson, P, et al.
Published: (2013)

Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis.
by: Rudwaleit, M, et al.
Published: (2009)

Reactive Arthritis Triggered by Adalimumab and Leflunomide in a Patient with Ankylosing Spondylitis
by: Liu Y, et al.
Published: (2022-12-01)

Adalimumab is effective and well-tolerated in patients with ankylosing spondylitis (AS) in day-to-day clinical practice - Results from rhapsody
by: Wordsworth, P, et al.
Published: (2008)

Combined analysis of three whole genome linkage scans for Ankylosing Spondylitis.
by: Carter, K, et al.
Published: (2007)

Effect of adalimumab on quality of life in patients with active ankylosing spondylitis
by: Cao Shuangyan, Shao Zhanqin, Gu Jieruo
Published: (2023-06-01)

EXPERIENCE OF TREATMENT OF JUVENILE ANKYLOSING SPONDYLITIS WITH EYES LESION WITH ADALIMUMAB
by: E.I. Alexeeva, et al.
Published: (2009-01-01)

EXPERIENCE OF TREATMENT OF JUVENILE ANKYLOSING SPONDYLITIS WITH EYES LESION WITH ADALIMUMAB
by: E.I. Alexeeva, et al.
Published: (2009-01-01)

Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab
by: M. Fernandes, et al.
Published: (2011-11-01)

Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis
by: Zena Chen, et al.
Published: (2021-09-01)

Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS)
by: van der Heijde, D, et al.
Published: (2008)

Real‐life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data
by: Sanjiv Kapoor, et al.
Published: (2019-10-01)

IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS), ADALIMUMAB IMPROVES INFLAMMATORY BOWEL DISEASE (IBD) AND PSORIASIS (Ps) AND PREVENTS ANTERIOR UVEITIS (AU) FLARES
by: Wordsworth, P, et al.
Published: (2009)

Early Adalimumab and Anti‐Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients
by: Xiaoliang Ding, et al.
Published: (2020-05-01)

Editorial: Ankylosing Spondylitis and Related Immune-Mediated Disorders
by: Maria Teresa Fiorillo, et al.
Published: (2019-06-01)

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation
by: C McLeod, et al.
Published: (2007-08-01)

LEUKOCYTOCLASTIC VASCULITIS ASSOCIATED WITH ADALIMUMAB TREATMENTIN A PATIENT WITH ANKYLOSING SPONDYLITIS
by: I A Doroshkevich, et al.
Published: (2010-06-01)

Eosinophilia in a patient with ankylosing spondylitis treated with prolonged adalimumab only
by: Junhong He, et al.
Published: (2022-02-01)

Allergic bronchopulmonary aspergillosis in a patient with ankylosing spondylitis treated with adalimumab
by: Yudai Suzuki, et al.
Published: (2021-08-01)

Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab
by: Dubravka Bosnić, et al.
Published: (2016-12-01)

ERAP1 and ankylosing spondylitis.
by: Keidel, S, et al.
Published: (2013)

Is there a higher genetic load of susceptibility loci in familial ankylosing spondylitis?
by: Joshi, R, et al.
Published: (2012)

Is There a Higher Genetic Load of Susceptibility Loci in Familial Ankylosing Spondylitis?
by: Joshi, R, et al.
Published: (2011)

Meta-analysis in ankylosing spondylitis (AS) - Genomewide linkage map including 589 affected sibling pairs
by: Carter, K, et al.
Published: (2005)

Meta-analysis in ankylosing spondylitis (AS) - Genomewide linkage map including 589 affected sibling pairs.
by: Carter, K, et al.
Published: (2005)

Secretor status and ankylosing spondylitis.
by: Pal, A, et al.
Published: (1998)

ARTS1 and ankylosing spondylitis
by: Harvey, D, et al.
Published: (2008)

Adalimumab (HUMIRA (R)) improves inflammatory bowel disease (IBD) and psoriasis (Ps) and prevents anterior uveitis (AU) flares in patients with Ankylosing spondylitis (AS)
by: Rudwaleit, M, et al.
Published: (2008)